Chargement en cours...

Extended-release oral capsule of carbidopa–levodopa in Parkinson disease

Motor fluctuations complicate the treatment of patients with Parkinson’s disease receiving levodopa. Extended-release carbidopa–levodopa has a pharmacokinetic profile that provides a more continuous levodopa serum concentration. Patients taking this formulation can expect longer duration of action a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ther Adv Neurol Disord
Auteurs principaux: Margolesky, Jason, Singer, Carlos
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5784558/
https://ncbi.nlm.nih.gov/pubmed/29399046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285617737728
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!